Auto majors Tata Motors and Bajaj Auto, and drug makers Dr Reddy’s Laboratories and Cipla were in focus on Dalal Street in early trade on Wednesday, ahead of the four companies' financial results due later in the day.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

Shares of Tata Motors and Bajaj Auto were flat with a positive bias at Rs 422.40 and Rs 3,693 per share on the NSE. While Cipla was down marginally to Rs 1,058.20 and Dr Reddy’s slipped more than 1 per cent to Rs 4,199.30 per share in the early morning trade.

What to expect from Tata Motors, Bajaj Auto, DRL and Cipla earnings reports

Tata Motors

According to Zee Business research, the Tata group auto company's quarterly may report of Rs 530 crore on a year-on-year basis, with a 14.5 per cent increase in revenue to Rs 82,710 crore and a 130-basis-point expansion in the margin, according to Zee Business research.

Also Read: Q3 Results Preview: Tata Motors set to narrow YoY losses; Bajaj Auto's December quarter net profit to jump over 12%

Bajaj Auto

Bajaj Auto’s net profit is estimated to increase 12.4 per cent to Rs 1,365 crore, with steady revenue and a 260-basis-point spike in the margin to 17.8 per cent, owing to easing raw material prices and currency changes, according to Zee Business research.

Also Read: Bajaj Auto Q3 Results Preview: Net profit likely to increase 12% with 260 bps margin expansion

Dr Reddy's Laboratories

According to Zee Business research, DRL's net profit is estimated to increase 24 per cent to Rs 874 crore with revenue growth at nine per cent to Rs 5,821 crore. 

The analysts peg the pharmaceutical major's margin at 24.6 per cent for the quarter ended December 2022, as against 22.5 per cent for the year-ago period.

Also Read: Claims against Dr Reddy's over Revlimid in US dismissed

Cipla

Cipla is estimated to report a 21 per cent jump in net profit to Rs 914 crore with 13 per cent growth in revenue to Rs 6,168 crore and expansion in the margin by 200 basis points to 24 per cent, according to Zee Business research.